Autologous haematopoietic stem cell transplants for autoimmune disease--feasibility and transplant-related mortality. Autoimmune Disease and Lymphoma Working Parties of the European Group for Blood and Marrow Transplantation, the European League Aga
about
Immune ablation and stem-cell therapy in autoimmune disease. Immunological reconstitution after high-dose immunosuppression and haematopoietic stem-cell transplantationImmune ablation and stem-cell therapy in autoimmune disease. Clinical experienceAutologous stem-cell transplantation in refractory autoimmune diseases after in vivo immunoablation and ex vivo depletion of mononuclear cellsSLE - hematopoietic stem cell transplantation for systemic lupus erythematosusThe effect of treatment with Campath-1H in patients with autoimmune cytopenias.Haematopoetic stem cell transplantation for refractory autoimmune cytopenia.Hematopoetic stem cell transplantation for immune thrombocytopenia and other refractory autoimmune cytopenias.Science, medicine, and the future: Tolerance and autoimmunityRetention of stemness and vasculogenic potential of human umbilical cord blood stem cells after repeated expansions on PES-nanofiber matrices.The myelin basic protein gene is expressed in differentiated blood cell lineages and in hemopoietic progenitors.Autologous blood stem cell transplantation as therapy for autoimmune diseases.High-dose immunosuppressive therapy for severe systemic sclerosis: initial outcomesImmunoablation and haemopoietic stem cell transplantation for severe autoimmune disease with special reference to systemic lupus erythematosus.Clinical management and treatment of vasculitis.Lupus: tinkering with haematopoietic stem cells.T lymphocyte activation--an inside overview.Stem cell transplantation in multiple sclerosis: multiple choices and multiple challenges.Resolution of psoriasis following allogeneic bone marrow transplantation for chronic myelogenous leukemia: case report and review of the literature.Intense immunosuppression and stem-cell transplantation for patients with severe rheumatic autoimmune disease: a review.The promise of hematopoietic stem cell transplantation for autoimmune diseases.Long-term follow-up of autologous stem cell transplantation for refractory juvenile idiopathic arthritis.Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin diseaseAutologous stem cell transplantation for refractory juvenile idiopathic arthritis: analysis of clinical effects, mortality, and transplant related morbidityAutologous stem cell transplantation in the treatment of systemic sclerosis: report from the EBMT/EULAR Registry.Hematopoietic stem cells: transcriptional regulation, ex vivo expansion and clinical application.Autologous stem cell transplantation for systemic lupus erythematosus.Cyclophosphamide: new approaches for systemic lupus erythematosus.Update on the diagnosis and management of refractory coeliac disease.Cardiac and cardiovascular consequences after haematopoietic stem cell transplantation.Autologous hematopoietic stem cell transplantation in autoimmune diseases.Bioreactors in tissue engineering - principles, applications and commercial constraints.Haematopoietic stem cell transplantation for poor-prognosis systemic sclerosis.The emerging global epidemic of paediatric inflammatory bowel disease--causes and consequences.Transplantation of Hematopoietic Stem Cells Promotes Functional Improvement Associated with NT-3-MEK-1 Activation in Spinal Cord-Transected Rats.Stem cell therapy for autoimmune disease: overview of concepts from the Snowbird 2002 tolerance and tissue regeneration meeting.High-dose cyclophosphamide for severe systemic lupus erythematosus.Improving safety of autologous haematopoietic stem cell transplantation in patients with Crohn's disease.Intense immunosuppression followed by purified blood CD34+ cell autografting in a patient with refractory juvenile rheumatoid arthritis.High-dose immunosuppression with autologous stem cell transplantation in severe refractory systemic lupus erythematosus.Donor lymphocyte infusions for refractory pure red cell aplasia relapsing after both autologous and nonmyeloablative allogeneic peripheral stem cell transplantation.
P2860
Q24791017-B9C8616B-D37B-4376-B9EE-3C3C82BC9489Q24791035-E047D2CF-4E83-47E0-91A4-C6BDF058099DQ24792552-AE7B11D6-74F8-43F6-8CC3-CFAD1C47363FQ24797491-9BC15F5E-80C3-4BF9-92E1-6510D165F629Q33339027-0E335415-FA87-43C4-A22E-0B60327A38C9Q33361139-1099A695-AB6B-4551-8EEA-DC12830CF91CQ33381818-E62A415D-AFD2-46F1-ADB0-7EF64BA6A1D6Q33817914-A0B5FCC0-A910-4E8D-B32B-0471AB1E7892Q34041306-E3A9E514-92D8-4FE2-A245-A78FFF9F6709Q34066117-F104B4AD-F96A-4B87-B383-092678D83156Q34157550-F6B14254-0FB5-4ED4-BBDB-1F09F9F1C0C8Q34208626-8DE7D0EB-E42D-490E-BB11-2E1EB30B0115Q34227063-ACE30D61-DBE7-4FE8-8E3E-5E7D13B9F7FAQ34395174-6CFD8A4F-B040-49D0-B0EC-CDD4CE687638Q34492010-8B93A95C-F813-4AE6-899B-B6629FC50B24Q34567937-647332A5-EE06-487B-9E85-8EAF6A864DBCQ34625037-87741E59-11B5-4D5F-B333-7FAF76ECB372Q34832781-F7F9E771-9B7F-49D8-BB89-9ED2835168F7Q35071105-4256D492-0045-46D4-B320-59BD07DC6D65Q35106133-AF4A29DB-71EC-4151-B1E0-4E7F49688C11Q35204115-150CA3C4-6395-4A75-A36A-7EBBC1D2B7DFQ35550480-F60AA605-10A5-4D2D-A0A6-5627BF54C0F2Q35553325-75B035AB-FDA2-42E0-92D6-C974C5208278Q35554404-CB49168A-60B8-429B-844F-228E7C1155AAQ35777496-6472B55D-7A41-436D-A45C-E6921ED4DF81Q35824509-D5E561EC-578F-4732-8A02-791BED191561Q35824515-64D5F664-A794-4D29-A970-E33DE3489FDFQ36879678-1971DF07-CD82-454D-9CA4-75184432574EQ37145279-D7998373-6B18-48E9-896D-A2390E9954D9Q37810087-57926694-E716-4780-BBE8-9A40771D870BQ38060677-C4502834-3AF9-462E-AF3E-2C8B24431DB4Q38466458-160C99CA-B844-488D-8247-CEFE1CCC51C3Q38583927-35797391-012D-4B48-A6C3-70271B55FBD1Q38645693-B9BA4649-9105-4AA7-95A6-9EC5FFD50D2CQ40567134-D0041CC2-16A2-45E7-982F-E68D7E764AC0Q40637742-992FADBA-21A9-407F-A96D-32D819DFBD68Q40903255-E256481F-0895-4AD6-8A30-A8789F85A3ACQ43558331-D9AB701B-D6DC-47FC-AC2E-09F5A1275B72Q44470266-481B47CF-D45F-4DA1-B159-0660449A1DF9Q44750609-1DFFE73A-9EBD-400D-8E45-F11F83D97D96
P2860
Autologous haematopoietic stem cell transplants for autoimmune disease--feasibility and transplant-related mortality. Autoimmune Disease and Lymphoma Working Parties of the European Group for Blood and Marrow Transplantation, the European League Aga
description
1999 nî lūn-bûn
@nan
1999 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Autologous haematopoietic stem ...... ation, the European League Aga
@ast
Autologous haematopoietic stem ...... ation, the European League Aga
@en
type
label
Autologous haematopoietic stem ...... ation, the European League Aga
@ast
Autologous haematopoietic stem ...... ation, the European League Aga
@en
prefLabel
Autologous haematopoietic stem ...... ation, the European League Aga
@ast
Autologous haematopoietic stem ...... ation, the European League Aga
@en
P2093
P50
P356
P1476
Autologous haematopoietic stem ...... Project for Autoimmune Disease
@en
P2093
Fouillard L
P2888
P304
P356
10.1038/SJ.BMT.1701987
P407
P577
1999-10-01T00:00:00Z
P5875
P6179
1016292600